nature 472 57- 63koeth r. a. wang z. levison b. s. buffa j. a. org e. sheehy b. t. britt e. b. fu x. wu y. li l. smith j. d. didonato j. a. chen j. li h. wu g. d. et al.

further research in this area may lead to strategies for the prevention of neurological disorders.metabolic diseases cardiovascular disease and non-alcoholic fatty liver disease nafldbecause the findings that bacterial metabolism of phos- phatidylcholine and l-carnitine lead to cardiovascular disease through production of trimethylamine and its subsequent conversion to trimethylamine n-oxide tmao in the liver 52 53 a number of additional metabolites have been identified that are associated with cardiovascular as well as non-alco- holic fatty liver disease nafld.2 using metabolomic anal- ysis over 15 microbial metabolites were identified as predic- tors of coronary heart disease as well as their associated microbial source 54. these metabolites included glcnac- 6-p mannitol and 15 unique choline metabolites.

u.s.a. 108 3047-3052braniste v. al-asmakh m. kowal c. anuar f. abbaspour a. to'th m. korecka a. bakocevic n. ng l. g. guan n. l. kundu p. gulya's b. halldin c. hultenby k. nilsson h. et al.

plos one 9 e87419caspi r. foerster h. fulcher c. a. kaipa p. krummenacker m. la- tendresse m. paley s. rhee s. y. shearer a. g. tissier c. walk t. c. zhang p. and karp p. d. 2008 the metacyc database of metabolic pathways and enzymes and the biocyc collection of pathwaygenome databases.

rep. 6 22525dumas m.-e. barton r. h. toye a. cloarec o. blancher c. rothwell a. fearnside j. tatoud r. blanc v. lindon j. c. mitchell s. c. hol- mes e. mccarthy m. i. scott j. gauguier d. and nicholson j. k. 2006 metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.

5 209abubucker s. segata n. goll j. schubert a. m. izard j. cantarel b. l. rodriguez-mueller b. zucker j. thiagarajan m. henrissat b. white o. kelley s. t. methe' b. schloss p. d. gevers d. et al.

22 586 -597wang z. klipfell e. bennett b. j. koeth r. levison b. s. dugar b. feldstein a. e. britt e. b. fu x. chung y.-m. wu y. schauer p. smith j. d. allayee h. tang w. h. et al.

furthermore conventionalization of gf mice with balbc microbiota caused an increase in anx- ious and timid behavior compared with mice receiving nih swiss microbiota 48.2 the abbreviations used are nafld non-alcoholic fatty liver disease ibd inflammatory bowel disease uc ulcerative colitis cd crohn's disease voc volatile organic compound bgc biosynthetic gene cluster scfa short chain fatty acid gf germ-free l-dopa levodopa gi gastrointestinal ahr aryl hydrocarbon receptor bbb blood-brain barrier.nafld displayed decreased levels of tyrosine valine 13-amin- oisobutyric acid pseudouridine and methylguanidine indica- tive of altered amino acid metabolism and rna turnover 56. these changes were in conjunction with improved body mass index and a reduction in histological fatty liver previously pub- lished within the same subjects 57. taken together fatty liver disease appears to be associated with altered metabolites that are either produced or influenced by gut microbes.conclusionaltogether advances in the fields of metabolomics and microbiome analyses have resulted in the newly identified func- tional roles of several metabolites such as scfas and trypto- phan derivatives.

8 46jansson j. willing b. lucio m. fekete a. dicksved j. halfvarson j. tysk c. and schmitt-kopplin p. 2009 metabolomics reveals metabolic biomarkers of crohn's disease.

u.s.a. 103 12511-12516miccheli a. capuani g. marini f. tomassini a. pratico g. ceccarelli s. gnani d. baviera g. alisi a. putignani l. and nobili v. 2015 urinary 1h-nmr-based metabolic profiling of children with nafld un- dergoing vsl3 treatment.

bioinformatics 26 2631-2632crusoe m. r. alameldin h. f. awad s. boucher e. caldwell a. cart- wright r. charbonneau a. constantinides b. edvenson g. fay s.fenton j. fenzl t. fish j. garcia-gutierrez l. garland p. et al.

48 315-321devkota s. wang y. musch m. w. leone v. fehlner-peach h. nad- impalli a. antonopoulos d. a. jabri b. and chang e. b.

11 639 - 648hadjithomas m. chen i.-m. chu k. ratner a. palaniappan k. szeto e. huang j. reddy t. b. cimermancvicv p. fischbach m. a. ivanovan.

51 2182-2194samb-ba b. mazenot c. gassama-sow a. dubourg g. richet h. hugon p. lagier j.-c. raoult d. and fenollar f. 2014 maldi-tof identification of the human gut microbiome in people with and without diarrhea in senegal.

60 1958 -1966lamas b. richard m. l. leducq v. pham h.-p. michel m.-l. da costa g. bridonneau c. jegou s. hoffmann t. w. natividad j. m. brot l. taleb s. couturier-maillard a. nion-larmurier i. merabtene f. et al.

